US HHS Pulled Recommendation To Make Kratom A Controlled Substance, But Kept Mum On Change
Agency Recently Disclosed 2018 Letter To DEA Rescinding Findings To Schedule Kratom
HHS released to industry proponents Reps. Mark Pocan and Morgan Griffith the letter it submitted in 2018 notifying DEA that it was rescinding recommendation it made in 2017 to list kratom active ingredients mitragynine and 7-hydroxymitragynine under Schedule I of the CSA.
